1. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020 Feb 13;6(1):11. https://doi.org/10.1038/s41572-020-0145-5. [DOI] [PubMed]

2. Farhan N, Jeffery S. Diagnosing Burn Wounds Infection: The Practice Gap & Advances with MolecuLight Bacterial Imaging. Diagnostics (Basel). 2021 Feb;11(2):268. https://doi.org/10.3390/diagnostics11020268. [DOI] [PubMed]

3. Yang Y, Zeng Q, Hu G, Wang Z, Chen Z, Zhou L, et al. Distribution of Nosocomial Pathogens and Antimicrobial Resistance among Patients with Burn Injuries in China: A Comprehensive Research Synopsis and Meta-Analysis. Infect Dis Ther. 2024 Jun;13(6):1291-313. https://doi.org/10.1007/s40121-024-00983-6. [DOI] [PubMed]

4. Abashidze I, Savitskaya I. Microbial landscape transformation in burn wounds as a predictor of delayed healing. Heliyon. 2026 Feb;12(2):e44536. [Link]

5. Chen H, Yang L, Cheng L, Hu XH, Shen YM. Distribution and drug resistance of pathogens in burn patients in China from 2006 to 2019. World J Clin Cases. 2021 Apr;9(10):2228-37. https://doi.org/10.12998/wjcc.v9.i10.2228. [DOI] [PubMed]

6. Emami A, Pirbonyeh N, Keshavarzi A, Javanmardi F, Moradi Ghermezi S, et al. Three Year Study of Infection Profile and Antimicrobial Resistance Pattern from Burn Patients in Southwest Iran. Infect Drug Resist. 2020 May;13:1499-506. https://doi.org/10.2147/idr.s249160. [DOI] [PubMed]

7. Fernández Salgueiro M, Cernuda Martínez JA, Gan RK, Arcos González P. Climate change and antibiotic resistance: A scoping review. Environ Microbiol Rep. 2024 Oct;16(5):e70008. https://doi.org/10.1111/1758-2229.70008. [DOI] [PubMed]

8. Hosseini M, Hasannejad-Bibalan M, Yaghoubi T, Mobayen M, Khoshdoz P, Khoshdoz S, et al. Prevalence and Antibiotic Resistance Pattern of Gram-Positive Isolates from Burn Patients in Velayat Burn Center in Rasht, North of Iran. MLJ. 2021;15(6):52-57. http://dx.doi.org/10.61186/mlj.15.6.52. [Link] [DOI]

9. Vinaik R, Barayan D, Shahrokhi S, Jeschke MG. Management and prevention of drug resistant infections in burn patients. Expert Rev Anti Infect Ther. 2019 Aug;17(8):607-19. https://doi.org/10.1080/14787210.2019.1648208. [DOI] [PubMed]

10. Kelly EJ, Oliver MA, Carney BC, Shupp JW. Infection and Burn Injury. Eur Burn J. 2022 Feb;3(1):165-79. https://doi.org/10.3390/ebj3010014. [DOI] [PubMed]

11. AbdelHalim MM, Abdel Salam SA, Elgendy MO, Abdel Hamied AM, Alshahrani SM, Ibrahim ARN, et al. A Retrospective Study on the Prevalence and Antimicrobial Susceptibility of Gram-Positive Cocci in a Pediatric Department: A Single-Center Report from Egypt. Medicina (Kaunas). 2025 Jun;61(6):1089. https://doi.org/10.3390/medicina61061089. [DOI] [PubMed]

12. Rahim Hateet R. Isolation and Identification of Some Bacteria Contemn in Burn Wounds in Misan, Iraq. Arch Razi Inst. 2021 Dec;76(6):1665-70. https://doi.org/10.22092/ari.2021.356367.1833. [DOI] [PubMed]

13. Singh V, Grover N, Tandel K, Jena S. Seven-year microbiological profile and antibiotic sensitivity pattern of burn wound infections in a tertiary care hospital in New Delhi. Indian J Burns. 2022 Jan;30(1):18-23. doi:10.4103/ijb.ijb_27_21. [Link] [DOI]

14. Roy S, Mukherjee P, Kundu S, Majumder D, Raychaudhuri V, Choudhury L. Microbial infections in burn patients. Acute Crit Care. 2024 May;39(2):214-25. https://doi.org/10.4266/acc.2023.01571. [DOI] [PubMed]

15. Verma G, Nayak SR, Jena S, Panda SS, Pattnaik D, Praharaj AK, et al. Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study. J Pure Appl Microbiol. 2023;17(4):2243-49. https://doi.org/10.22207/JPAM.17.4.21. [Link] [DOI]

16. Nedelcheva G, Dobreva D, Kuyumdzhiev T, Tsankova G, Todorova T. Etiological structure and antibiotic resistance pattern of burn wound infections in hospitalized patients - a one-center study in Varna, Bulgaria. New Microbiol. 2024 Jul;47(2):146-51. [PubMed]

17. Tafreshi N, Babaeekhou L, Ghane M. Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of blaOXA-24-like and blaOXA-58-like genes. Iran J Microbiol. 2019 Dec;11(6):502-509. [PubMed]

18. Ranjbar R, Farahani A. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrob Resist Infect Control. 2019 Nov;8:172. https://doi.org/10.1186/s13756-019-0612-5. [DOI] [PubMed]

19. Thy M, Timsit JF, de Montmollin E. Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens. Antibiotics (Basel). 2023 May;12(5):860. https://doi.org/10.3390/antibiotics12050860. [DOI] [PubMed]

20. Corona A, De Santis V, Agarossi A, Prete A, Cattaneo D, Tomasini G, et al. Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review. Antibiotics (Basel). 2023 Jul;12(8):1262. https://doi.org/10.3390/antibiotics12081262. [DOI] [PubMed]

21. Kolaventi SS, Moharana L, Sairam K, Dhingra L, Singh T, Sethi D. Exploring Multi-Drug Resistance Mechanisms in MBL-Producing Gram-Negative Bacteria Isolated from Hospitalized Patients: A Phenotypic Analysis. Seminars in Medical Writing and Education. 2024 Dec;3:523. https://doi.org/10.56294/mw2024523. [Link] [DOI]